tiprankstipranks
Trending News
More News >
Talis Biomedical (TLIS)
OTHER OTC:TLIS
US Market

Talis Biomedical (TLIS) Income Statement

Compare
45 Followers

Talis Biomedical Income Statement

Last quarter (Q2 2024), Talis Biomedical's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q2, Talis Biomedical's net income was $-8.85M. See Talis Biomedical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 412.00K$ 3.65M$ 0.00$ 10.94M$ 3.98M
Gross Profit
$ 371.00K$ -4.74M$ -2.62M$ 9.56M$ 3.98M
Operating Expenses
$ 67.19M$ 110.40M$ 197.39M$ 100.75M$ 26.70M
Depreciation and Amortization
$ 770.00K$ 11.60M$ 2.62M$ 1.37M$ 726.00K
EBITDA
$ -66.05M$ -101.41M$ -189.41M$ -89.76M$ -25.97M
Operating Income
$ -66.81M$ -112.71M$ -200.01M$ -91.18M$ -26.70M
Other Income/Expenses
$ 4.81M$ -306.00K$ 7.97M$ 54.00K$ -775.00K
Pretax Income
$ -62.01M$ -113.01M$ -192.04M$ -91.13M$ -27.47M
Net Income
$ -62.01M$ -113.01M$ -190.46M$ -91.08M$ -27.43M
Per Share Metrics
Basic EPS
$ -34.12$ -63.65$ -126.13$ -314.06$ -182.88
Diluted EPS
$ -34.12$ -63.65$ -126.13$ -314.06$ -182.88
Weighted Average Shares Outstanding
1.82M 1.78M 1.51M 290.00K 150.00K
Weighted Average Shares Outstanding (Diluted)
1.82M 1.78M 1.51M 290.00K 150.00K
Currency in USD

Talis Biomedical Earnings and Revenue History